Pre-treatment prediction of response to peginterferon plus ribavirin in chronic hepatitis C genotype 3 | Zendy

Sebastián Marciano | Zendy; Silvia Borzi | Zendy; Melisa Dirchwolf | Zendy; Ezequiel Ridruejo | Zendy; Manuel Mendizábal | Zendy; Fernando Bessone | Zendy; M.E. Sirotinsky | Zendy; Diego Giunta | Zendy; Julieta Trinks | Zendy; Pablo A. Olivera | Zendy; Omar Galdame | Zendy; Marcelo Silva | Zendy; Hugo Fainboim | Zendy; Adrían Gadano | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Pre-treatment prediction of response to peginterferon plus ribavirin in chronic hepatitis C genotype 3

Author(s) -

Sebastián Marciano,

Silvia Borzi,

Melisa Dirchwolf,

Ezequiel Ridruejo,

Manuel Mendizábal,

Fernando Bessone,

M.E. Sirotinsky,

Diego Giunta,

Julieta Trinks,

Pablo A. Olivera,

Omar Galdame,

Marcelo Silva,

Hugo Fainboim,

Adrían Gadano

Publication year - 2015

Publication title -

world journal of hepatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.913

H-Index - 55

ISSN - 1948-5182

DOI - 10.4254/wjh.v7.i4.703

Subject(s) - medicine , ribavirin , gastroenterology , hepatitis c virus , hepatitis c , genotype , fibrosis , steatosis , liver disease , immunology , virus , gene , biochemistry , chemistry

To evaluate pre-treatment factors associated with sustained virological response (SVR) in patients with hepatitis C virus (HCV) genotype 3 treated with peginterferon and ribavirin (RBV).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research